Mentice publishes Annual Report 2023
Read more
Mentice receives an order of USD 795,000 for development services from a world leading MedTech Company
Read more

Access denied

Due to applicable legal restrictions, the information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States of America, Australia, Hong Kong, Japan, Canada, New Zealand, Singapore, South Africa or any other jurisdiction in which such release, publication or distribution would be unlawful.

We apologize for any inconvenience this may cause.

BACK TO investor